VERU

Serial Number 88810546
734

Registration Progress

Application Filed
Feb 25, 2020
Under Examination
May 30, 2023
Approved for Publication
Apr 4, 2023
Published for Opposition
Apr 4, 2023
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: May 30, 2026 111 days
Statement of Use required (all extensions used)

Trademark Image

VERU

Basic Information

Serial Number
88810546
Filing Date
February 25, 2020
Published for Opposition
April 4, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
734
Status Date
Oct 31, 2025
Application
Pending
Classes
005

Rights Holder

Veru Inc.

03
Address
2916 N. Miami Avenue, Suite # 1000
MIAMI, FL 33127

Ownership History

Veru Inc.

Original Applicant
03
MIAMI, FL

Veru Inc.

Owner at Publication
03
MIAMI, FL

Legal Representation

Attorney
Jacqueline Zion

USPTO Deadlines

Next Deadline
111 days remaining
NOA E-Mailed - SOU Required
Due Date
May 30, 2026

Application History

46 events
Date Code Type Description Documents
Nov 1, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 31, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 28, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 29, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 2, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 2, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 1, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
May 1, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 2, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 25, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 25, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 19, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 25, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 19, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 21, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 20, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 20, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
May 20, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 30, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 30, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 30, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 30, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 4, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 4, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 15, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 27, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 7, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 7, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 7, 2023 ALIE A ASSIGNED TO LIE Loading...
Jan 31, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Nov 28, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Jun 29, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 29, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 29, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 25, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Aug 20, 2021 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Dec 2, 2020 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Nov 30, 2020 ALIE A ASSIGNED TO LIE Loading...
May 13, 2020 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
May 13, 2020 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
May 13, 2020 CNSL R SUSPENSION LETTER WRITTEN Loading...
May 13, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 5, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 4, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 28, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceuticals and biopharmaceuticals for use in oncology, oncology supportive care and animal oncology; pharmaceuticals and biopharmaceuticals for use in urology; pharmaceuticals for use in benign prostatic hyperplasia and prostate enlargement

Additional Information

Design Mark
The mark consists of the word "VERU" in a stylized font with a chevron to the top right of the word.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005